Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

4D Molecular Therapeutics (FDMT) Other financing activities: 2022

Historic Other financing activities for 4D Molecular Therapeutics (FDMT) over the last 1 years, with Dec 2022 value amounting to $468,000.

  • 4D Molecular Therapeutics' Other financing activities rose 128.07% to $260,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $437,000, marking a year-over-year increase of 21.39%. This contributed to the annual value of $468,000 for FY2022, which is N/A change from last year.
  • As of FY2022, 4D Molecular Therapeutics' Other financing activities stood at $468,000.
  • In the past 5 years, 4D Molecular Therapeutics' Other financing activities registered a high of $468,000 during FY2022, and its lowest value of $468,000 during FY2022.
  • Moreover, its 1-year median value for Other financing activities was $468,000 (2022), whereas its average is $468,000.